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Pathogenic Acinetobacter species, including Acinetobacter
baumannii and Acinetobacter nosocomialis, are opportunistic
human pathogens of increasing relevance worldwide. Although
their mechanisms of drug resistance are well studied, the viru-
lence factors that governAcinetobacterpathogenesis are incom-
pletely characterized. Herewe define the complete secretome of
A. nosocomialis strainM2 inminimalmedium and demonstrate
that pathogenicAcinetobacter species produceboth a functional
type I secretion system (T1SS) and a contact-dependent inhibi-
tion (CDI) system. Using bioinformatics, quantitative proteo-
mics, and mutational analyses, we show that Acinetobacter uses
its T1SS for exporting two putative T1SS effectors, an Repeats-
in-Toxin (RTX)-serralysin-like toxin, and the biofilm-associ-
ated protein (Bap). Moreover, we found that mutation of any
component of the T1SS system abrogated type VI secretion
activity under nutrient-limited conditions, indicating a previ-
ously unrecognized cross-talk between these two systems. We
also demonstrate that the Acinetobacter T1SS is required for
biofilm formation. Last, we show that both A. nosocomialis and
A. baumannii produce functioning CDI systems that mediate
growth inhibition of sister cells lacking the cognate immunity
protein. The Acinetobacter CDI systems are widely distributed
across pathogenicAcinetobacter species,withmanyA. bauman-
nii isolates harboring two distinct CDI systems. Collectively,
these data demonstrate the power of differential, quantitative
proteomics approaches to study secreted proteins, define the
role of previously uncharacterized protein export systems, and
observe cross-talk between secretion systems in the pathobiol-
ogy of medically relevant Acinetobacter species.
Medically relevant Acinetobacter species are nosocomial
pathogens accounting for 2% of all healthcare-associated
infections in the United States (1). More alarming has been the
increasing rate of multidrug resistance (MDR)7 phenotypes
associated with Acinetobacter-induced infections; so much so
that the CDC has listed Acinetobacter as a severe threat, and
last-line therapeutic options like carbapenems, tigecycline, and
colistin are now the recommended treatment options for the
majority ofAcinetobacter infections (2, 3). Furthermore, recent
epidemiological data indicate thatAcinetobacter spp. appear to
be acquiring MDR phenotypes faster than almost all other
Gram-negative bacteria over the last decade (4).
For decades, the causative agent behind Acinetobacter in-
fections was almost exclusively reported as Acinetobacter
baumannii; however, Acinetobacter taxonomy has undergone
major modifications over the last several years. Specifically, we
now know that medically relevant Acinetobacter spp. predom-
inately come from a single group, designated the Acinetobacter
baumannii (Ab) group, given their close genetic relatedness
and indistinguishability at the phenotypic level when exam-
ined in clinical laboratories. Members of the Ab group include
A. baumannii, Acinetobacter nosocomialis, Acinetobacter pit-
tii, Acinetobacter seifertii, and Acinetobacter dijkshoorniae, all
of which act as opportunistic pathogens and acquireMDR phe-
notypes (5–7). Nevertheless, A. baumannii still remains the
most comprehensively studied member of the Ab group, with
A. nosocomialis a distant second.
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Although our understanding of the mechanisms that medi-
ate MDR phenotypes is quite comprehensive (8), those that
mediate Acinetobacter pathogenesis are only beginning to be
defined. The role of secretion systems in Acinetobacter viru-
lence has been receiving more and more attention because of
their importance in other clinically relevant pathogens. Multi-
ple secretion systems, including a type II secretion system
(T2SS), a type V secretion system (T5SS), and a T6SS, have all
been characterized and attributed specific roles in the pathobi-
ology of Acinetobacter (9–13). Both the T2SS and T5SS have
clear roles in pathogenesis, as specific exported factors have
been directly linked to virulence, including the type II effector
CpaA and the type V autotransporter Ata (11, 14). The T6SS,
not yet linked directly to eukaryotic pathology, is responsible
for killing bacteria and commonly found to be active in clinical
isolates extracted from polymicrobial infections, indicating
that itmay impart a fitness advantage in vivo (15). Furthermore,
plasmid-borne conjugation systems similar to a T4SS have also
been identified in A. baumannii (16), but detailed molecular
analyses describing these systems are lacking. Lastly, type IV
pili (T4P), bacterial grappling hooks evolutionarily related to
the T2SS, have also been characterized in Acinetobacter for
their role in natural transformation, motility, and biofilm for-
mation (17, 18).
Given the extensive genetic variation of Acinetobacter spp.
and our lack of a thorough understanding of their molecular
pathogenesis, we hypothesized that other unrecognized
secreted factors may be contributing toward Acinetobacter
fitness and virulence. To this end, we bioinformatically iden-
tified, in Ab group member genomes, a T1SS and contact-
dependent inhibition (CDI) systems. The T1SS of Acineto-
bacter is homologous to the prototypical TolC-HlyD-HlyB
system from Escherichia coli for export of the hemolysin
HlyA (19). This three-component secretion system requires
an inner membrane ATP-binding cassette (ABC) trans-
porter, a periplasmic adaptor protein (PAP), and an outer
membrane protein channel (20).
In E. coli, TolC acts as the outer membrane protein and
forms a homotrimer that embeds into the outer membrane,
extending far into the periplasmic space, where it can interact
with the periplasmic adaptor protein HlyD (21). The periplas-
mic adaptor protein HlyD, anchored by a transmembrane
domain within the inner membrane (22), not only interacts
with the outer membrane protein TolC and the ABC trans-
porter HlyB but can also interact with the T1SS substrate via
an N-terminal cytoplasmic region (23). The ABC transporter
HlyB, also embedded within the inner membrane, hydrolyzes
ATP to provide the energy required for export of a specific
T1SS substrate (22). Together, these proteins act to facilitate
the secretion of unfolded effectors directly from the cytoplasm
to the extracellular environment.
CDI systems, first discovered in 2005 (24), constitute a tri-
partite mechanism for inhibiting the growth of neighboring
bacteria independent fromT6SS. Both CdiB and CdiA are con-
sidered to be T5SS, where the outer membrane pore-forming
CdiB protein facilities the export of a CdiA toxin to the cell
surface. CdiA toxins are polymorphic, usually containing mul-
tiple filamentous hemagglutinin domains in the N-terminal
region and a C-terminal toxin domain. The third component,
the CdiI protein, acts as an immunity protein preventing auto-
inhibition. Immunity proteins commonly contain domains
associated with the SUKH superfamily (25). A fourth compo-
nent, the toxin receptor, is also required for CDI killing; how-
ever, these are not intuitively identifiable and are not associated
with cdiBAI loci. To date, only a handful of other CDI systems
(Dickeya dadantii (26),Burkholderia (26), Enterobacter cloacae
(27), Pseudomonas aeruginosa (28), and Neisseria meningitidis
(29)) have been functionally characterized. Here, utilizing a
quantitative, differential proteomics technique paired with
bioinformatics, we report the complete secretome ofA. nosoco-
mialis strain M2 and simultaneously identify two previously
unrecognized secretion systems across medically relevant
Acinetobacter species.
Results
Identification of a T1SS-associated locus and its role in the
secreted protein profile of A. nosocomialis strainM2
Previously, we demonstrated that A. nosocomialis strain M2
(formerly designated A. baumannii strain M2 (30)) has a func-
tioning T2SS that secretes multiple effectors, including the
metalloprotease CpaA (10). Furthermore, given that strain M2
also encodes for a functioning T6SS (12), we hypothesized that
other secretion systems not yet characterized may also be con-
tributing to the secreted protein profile. Using a BLASTp
search, we identified homologs of the T1SS components tolC,
hlyB, and hlyD fromE. coli (Fig. 1A). To determinewhether this
putative system was contributing toward the secreted protein
profile in strain M2, we constructed a tolC-hlyB-hlyD::kan
mutant (T1SS mutant). Using one-dimensional SDS-PAGE
analysis, we found that the T1SS mutant exhibited an altered
secreted protein profile, as evidenced by the absence of high-
molecular-weight proteins at 70, 130, and 250 kDa compared
with the parent (Fig. 1B). Importantly, the complemented
strain displayed a secreted protein profile nearly identical to the
parental strain, indicating that the absence of the tolC-hlyB-
hlyD gene cluster was responsible for the observed phenotype
(Fig. 1B). Next, we sought to further characterize these differ-
ences and simultaneously define the complete secretome of
strain M2 in minimal medium.
The complete secretome of A. nosocomialis strainM2 reveals
T1SS-, T2SS-, T6SS-, and CDI-secreted candidates
To define the complete secretome and simultaneously iden-
tify differentially secreted proteins between strain M2 and the
T1SS mutant, we utilized a quantitative proteomics approach.
Briefly, we enriched for secreted proteins from each strain
using bacteria grown to mid-log in M9 minimal medium sup-
plemented with 0.2% casamino acids. This method eliminated
the use of richmedium containing high concentrations of yeast
proteins as well as limited cellular lysis contaminants found in
stationary-phase bacterial cultures. Using dimethyl labeling of
enzymatically digested peptides obtained from the secreted
protein fractions of each strain, we were then able to compare
the relative quantities of all secreted proteins in pairwise fash-
ions. Four biological samples were prepared for each strain and
processed as described under “Experimental Procedures” prior
Pathogenic Acinetobacter species have a T1SS and CDI system
9076 J. Biol. Chem. (2017) 292(22) 9075–9087
 at W
ashington U









to LC/MS analysis. Isotopically labeled samples were then
pooled, and the four biological dimethylation triplex experi-
ments were analyzed by LC/MS. A sample of each replicate for
each strain was run on an SDS-PAGE gel, silver-stained, and
found to have similar loadings and reflected the overall secre-
tion trend observed in Fig. 1 (supplemental Fig. 1).
First we compiled a list of the top secreted proteins from the
wild-type M2. Our list was ranked based on proteins with the
highest number of unique identified peptides (arbitrarily cut off
at 20 for Fig. 1C). The complete list of proteins can be found
in the supplemental Mass Spectrometry Table. We identified
components of the T6SS and the T2SS, which was expected
given previous characterizations of these systems in pathogenic
Acinetobacter spp. Furthermore, we identified proteins puta-
tively associatedwith theT1SS and aCDI system, both ofwhich
are discussed in detail below.
RTX and Bap are secreted via a T1SS
Using the Log2 ratio of high-confidence proteins (defined as
proteins with13 unique identified peptides) observed across
replicates, we were able to identify multiple proteins that were
significantly and differentially secreted by the wild type com-
pared with the T1SS mutant (Fig. 2A). As expected, the top
differentially secreted protein between the parent and the T1SS
mutant was a predicted T1SS protein based on the presence of
the type I secretion C-terminal target domain (VC_A0849) in
the C terminus of the M215_09430 open reading frame. The
M215_09430 locus encodes for a protein containing multiple
peptidase M10 serralysin C-terminal domains, a Ca2-binding
protein RTX toxin-related domain, and the type I secretion
C-terminal target domain (VC_A0849 subclass). For simplicity,
we will refer toM215_09430 as the RTX protein.We also iden-
tified a second protein containing a type I secretion C-terminal
Figure1.Acinetobacter nosocomialis strainM2encodes for a functional T1SS.A, genetic arrangement and locus identifiers for the T1SS locus in strainM2.
Boxes below each gene contain the relevant protein family domain information associated with the respective amino acid sequence for TolC, HlyB, and HlyD,
as determined by BLASTp. B, Coomassie-stained, one-dimensional SDS-PAGE analysis of the secreted protein profiles from thewild-typeM2, the T1SSmutant
(tolC-hlyD::kan), and the complemented T1SSmutant. Secreted proteins were enriched from bacteria grown overnight in rich medium. C, the most abundant
high-confidence secreted proteins from strainM2 grown tomid-log inminimalmedium. High-confidence proteins were defined as proteins with20 unique
identified peptides across replicates. The export column details the export/secretion mechanism for the each protein. The asterisk beside T1SS denotes
putative secretion by the TolC-HlyB-HlyD system, as determined by the presence of the type I secretion C-terminal target domain (VC_A0848) forM215_09430
and M215_01695 and the absence of these proteins in our differential proteomics analysis comparing secreted proteins from the wild type and the T1SS
mutant, described in detail in Fig. 2.
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target domain, M215_01695, which was significantly and dif-
ferentially secreted between the wild type and T1SS mutant.
The M215_1695 locus encodes for a large protein predicted to
containmultiple group 3 bacterial Ig-like domains (pfam13754)
and a type I secretion C-terminal target domain (VC_A0848).
Given its homology to biofilm-associated proteins (Baps) in
A. baumannii, this protein was designated the Bap ortholog in
A. nosocomialis strain M2.
The second most differentially secreted protein between the
wild type and the T1SS mutant was M215_02910 (Fig. 2, A and
B), a protein predicted to contain multiple group 3 bacterial
Ig-like domains (pfam13754) similar to Bap; however, the pro-
tein annotation for M215_02910 lacks the type I secretion
C-terminal target domain commonly found in T1SS proteins.
Recentmolecular, in silico, and PCR analyses of bap genes from
A. baumannii demonstrate that the bap repetitive elements are
prone to alignment errors in genome sequences, resulting in
premature truncations and chromosomal rearrangements (31–
33). Together, this may indicate thatM215_02910 is part of the
same open reading frame as Bap. Conversely, it is also possible
that this open reading framehas been incorrectly aligned and is,
in fact, part of the RTX protein, given its similarities to large
repetitive RTX proteins (34). Regardless, the presence of pep-
tides from this protein in the secreted fraction of both the wild
type and complemented strain strongly correlate with its secre-
tion with the T1SS.
Mutation of the T1SS reveals cross-talk between other
secretion systems
Analysis of our proteomics results indicated that proteins
without the type I C-terminal targeting domain were also dif-
ferentially secreted between thewild type and theT1SSmutant.
Specifically,multiple T6SS-associated proteins, including three
VgrG orthologs and Hcp, were all found at significantly lower
levels in the T1SS mutant. Although not nearly as significant,
multiple known T2SS-associated proteins, including CpaA,
LipH, a rhombosortase, and a rhombotarget, were also found in
lower quantities in the T1SS mutant compared with the wild
type. Last, a predicted CDI-associated protein was also identi-
fied as significantly reduced in the T1SS mutant (discussed in
detail below). The full list of differentially secreted proteins can
be found in the supplementalMass SpectrometryTable. For the
majority of instances, including the predicted T1SS-associated
proteins described above, the dimethylation ratios comparing
the secreted proteins from the complemented strain with the
parent strain were quite similar, again indicating that the ab-
sence of the tolC-hlyB-hlyD genes was responsible for the dif-
ferential secretion profile in the mutant.
Deletion of the T1SS systems represses T6SS activity in
minimalmedium only
It has been shown previously that deletion of tolC can have
pleiotropic effects on membrane integrity and cellular physiol-
ogy in E. coli (35). Therefore, we initially hypothesized that the
observed differences between the secreted proteins of the par-
ent and T1SS mutant were due to membrane stress associated
with the absence of the TolC protein. To gain insight into the
molecular mechanism behind the diminished protein profile of
the T1SS mutant and more intricately probe the role of tolC,
hlyB, and hlyD in the observed phenotypes, we constructed
in-frame unmarkedmutations in each gene as well as the entire
locus.
First we validated the quantitative proteomics results by
Western blotting across the entire mutant panel in minimal
Figure 2. Quantitative proteomics analysis comparing secreted proteins from strain M2, the T1SS mutant, and the complemented strain demon-
strates global changes to the secretome. A, heatmap of quantitative proteomics results of high-confidence proteins (defined as proteins with13 unique
identifiedpeptides). The Log2 ratio of high-confidenceproteins observed across replicates demonstrates the loss ofmultiple proteins in response todisruption
of T1SS (low tolC-hlyD/WT demethylation ratios). Upon restoration of T1SS in the form of the complemented strain, secreted protein profiles return to near
wild-type levels (complement/WT demethylation ratios of0). B, scatterplot of quantitative proteomics results showing thelog10 (p values) comparedwith
the average tolC-hlyD/WT ratios of alterations observed within the secretome of tolC-hlyD biological replicates compared with WT replicates. Statistically
significant changes (p 0.05) are highlighted in red.
Figure 3.Mutation of any component of the T1SS abrogates T6SS activity, as determined byHcp secretion inminimalmediumonly. A and B, Western
blot analysis probing for Hcp expression and secretion from thewild type and T1SSmutant panel and complemented strains grown inminimalmedium (A) or
rich medium (B). Hcp expression in whole cells from strains grown in either minimal or rich medium was equal. However, Hcp secretion was found to be
suppressed in strains with mutations in any component of the T1SS in minimal medium. Importantly, complemented strains had Hcp secretion levels
approximately equivalent to the wild type, with the exception of the hlyB complement, which had an intermediate phenotype. As a loading and lysis control,
RNA polymerase expression was probed for across all conditions. C, whole cells; S, secreted proteins.
Pathogenic Acinetobacter species have a T1SS and CDI system
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medium. As expected, Hcp expression was found to be similar
across all strains tested; however, Hcp secretion was not
detected in any of themutants analyzedwhen secreted proteins
were collected from strains grown in minimal medium (Fig.
3A). Interestingly, when the mutant panel was tested for Hcp
secretion from strains grown in rich medium, no differences
were observed in Hcp expression or secretion (Fig. 3B).
Next we sought to determinewhether the cross-talk between
the T1SS system and the T6SS was specific or whether disrupt-
ing other secretions systems would also abrogate T6SS activity.
To this end, we probed for Hcp expression and secretion in a
pilD mutant and complemented strain. PilD is the pre-pilin
peptidase required for processing of both pilins and pseudopi-
lins for the T4P system and T2SS, respectively. Thus, the
absence of pilD results in a T4P- and T2SS-negative phenotype
(10). The pilDmutant displayed no differences in Hcp expres-
sion or secretion compared with the parental strain and the
complemented strain. Furthermore, this phenotype held true
for both rich and minimal medium (Fig. 4, A and B).
The T1SS system is required for biofilm formation
Given that Bap was one of the most differentially secreted
proteins between the wild type and the T1SS full locus mutant,
we hypothesized that our unmarked individual T1SS mutants
would have impaired ability to formbiofilms.Using amicrotiter
plate biofilm assay, we observed that mutants lacking any or all
components of the T1SS have severely reduced ability to form
biofilms, as determined by crystal violet staining both 3 and 6 h
after inoculation (Fig. 5,A and B, respectively). Importantly, we
performed biofilm formation assays in rich medium to avoid
confounding results from altered secretion of non-T1SS com-
ponents, like Hcp secretion, as shown in Fig. 3. Nevertheless,
the attenuated biofilmphenotypewas observed in both rich and
minimal medium (data not shown). The biofilm defect was not
due to alterations in Csu pili or T4P expression and surface
presentation either. Specifically, the major pilin subunits PilA
of the T4P and CsuA/B of Csu pili were equally expressed in
whole cells and on the surface of all mutants and comple-
mented strains (supplemental Fig. 2). Last, the biofilm pheno-
type was not due to differences in the second most abundantly
secreted protein, M215_12375 (CdiA), as a cdi locus mutant
had the same level of biofilm as the parent strain (supplemental
Fig. 3).
T1SSmutants appear to have attenuated virulence
phenotypes in a Galleriamellonella infectionmodel
The greater wax moth, G. mellonella, is a commonly used
model system for measuring Acinetobacter virulence and cor-
relates well with in vivo virulence in mammalian systems (36).
To assess the role of the T1SS in virulence, we individually
infected larvae with the wild type, a T1SSmutant, or its respec-
tive complemented strain and monitored larva viability over
24 h. Larvae were injected with 10 l of a bacterial suspension
determined previously to be the LD50 for thewild-typeM2 (10).
Although not statistically significant, a clear virulence attenua-
tion trendwas observed in all T1SSmutants comparedwith the
parental or complemented strains, indicating that the T1SS
contributes to the pathogenicity of medically relevant Acineto-
bacter spp. (Fig. 6, A–D). Although the T1SS mutant has an
altered T6SS phenotype in minimal medium only, we have
demonstrated previously that T6SS mutants are equally as vir-
ulent as wild-type A. baumannii (13).
Pathogenic Acinetobacter spp. utilize a contact-dependent
inhibition system for bacterial killing
Two of the most abundantly secreted proteins, based on
observed peptides within our datasets, were the RTX protein
and M215_12375. Both proteins show profound alterations in
their secretion between the T1SS mutant and the wild-type
strain. As mentioned above, the RTX protein is an RTX serra-
lysin-like protein, a common class of toxins secreted by T1SS
(37), whereas theM215_12375 locus encodes for a polymorphic
toxin similar to those found in CDI systems (Fig. 7A). Given its
homology to CDI systems and the data presented below, we
have designated this gene cluster the cdiBAIM2 system (Fig. 7A).
Figure 4. Mutation of both the T2SS and T4P system does not abrogate
T6SS. A and B, Western blot analysis probing for Hcp expression and secre-
tion from wild-type M2, a pilD mutant, and the pilD complemented strain
grown in minimal medium (A) or rich medium (B). Both Hcp expression and
secretion were equivalent across strains grown in minimal medium or rich
medium. As a loading and lysis control, RNA polymerase (RNAP) expression
was probed for across all conditions.
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To determine whether the cdiBAIM2 system was active in
strain M2, the entire locus was replaced with a kanamycin cas-
sette, generating the M2cdi mutant. Furthermore, we gener-
ated a variant of the cdimutant expressing just the cdiI immu-
nity gene in trans. Next we performed inhibition assays in
pairwise fashions. As seen in Fig. 7B, M2 is able to inhibit the
growth of the cdimutant by1 log compared with co-incuba-
tions between the cdi mutant and the cdi mutant expressing
just the immunity protein. Furthermore, M2 is not able to
inhibit the growth of the cdimutant expressing just the immu-
nity protein, indicating that CdiI is indeed the immunity pro-
tein for this cdi system. Last, CDI killing was found to be T6SS-
independent, as an hcpmutant co-incubatedwith a double hcp/
cdimutant had an indistinguishable phenotype from wild-type
M2 co-incubated with the cdimutant (Fig. 7B).
CDI systems are conserved inmedically relevant Acinetobacter
To expand our findings to the majority of medically relevant
Acinetobacter spp., we bioinformatically identifiedCDI systems
in A. baumannii 19606 and 1225, two clinical isolates repre-
senting a type strain as well as newer, more relevant clinical
isolate, respectively. Interestingly, both A. baumannii 19606
and 1225 encode for two predicted cdi loci, a trait common to
P. aeruginosa (28). CDI loci from 19606 and 1225 were similar
in gene architecture to A. nosocomialis strain M2 with a puta-
tive transporter protein, the polymorphic toxin, and an immu-
nity protein. For both strains, each cdi locus was individually
mutated, generating cdi_1 and cdi_2 mutants for both 19606
and 1225. Subsequently, the cdi_1 and cdi_2mutantswere indi-
vidually co-incubated with their respective isogenic parent
strains for determination of growth inhibition. Similarly to the
strain M2 co-incubations, 19606 and 1225 mutants lacking
their respective cdi systems had their growth inhibited by 1
log comparedwith co-incubations between thewild-type strain
and a cdimutant complemented with the respective immunity
protein (Fig. 7, C and D). In each case, the difference between
the parent strain and a cdi mutant was statistically significant,
whereas co-incubations between a parent strain and a cdi
mutant expressing the immunity protein closely reflected the
growth of the cdi mutant in the absence of an inhibitor strain
(Fig. 7, C and D, last columns).
Discussion
Pathogenic Acinetobacter spp., including A. baumannii and
A. nosocomialis, are opportunistic pathogens with an un-
matched ability to acquire MDR phenotypes. Although the
mechanisms behind drug resistance are well documented, the
full slate of virulence factors that mediate virulence are not yet
defined. In this work, we applied quantitative proteomics tech-
niques to identify previously uncharacterized, secreted Acin-
etobacter proteins. This powerful approach, coupled with
previous secretion system characterizations, facilitated the
assignment of the complete secretome ofA. nosocomialis strain
M2 in minimal medium. Importantly analysis of the top se-
creted candidates revealed the presence of a functional T1SS
and identified two putative T1SS effectors. Last, we found func-
tional CDI systems in both A. nosocomialis strain M2 and two
A. baumannii clinical isolates, 19606 and 1225.
Bacterial interactions with the extracellular environment are
commonly mediated through secreted proteins; however, the
full arsenal of Acinetobacter secretion systems compared with
other classical pathogens like P. aeruginosa is significantly
undercharacterized. Nevertheless, a broad collection of publi-
cally available sequenced Acinetobacter genomes has allowed
the in silico identification of previously characterized secretion
systems important for pathogenesis in other bacteria. Using
this approach, we were able to identify a T1SS locus in A. noso-
comialis strain M2, homologous to the E. coli prototype T1SS
containing tolC, hlyB, and hlyD genes (19). Unlike E. coli, how-
ever, the tolC, hlyB, and hlyD genes of strain M2 are in a three-
gene cluster and are most likely in an operon, given that the
open reading frame for hlyB overlaps with both tolC and hlyD.
Furthermore, this gene arrangement is commonly found across
medically relevantAcinetobacter spp., includingA. baumannii,
with 88% identity conserved to the nucleotide level for com-
monly used laboratory strains like A. baumannii ATCC 17978,
AB5075, AYE, ACICU, and AB307-0294. Furthermore, homo-
Figure 5. TheAcinetobacter T1SS is required for biofilm formation. A and
B, biofilm formation was assessed by crystal violet staining. Plates were stat-
ically incubated at 37 °C for 3 h (A) or 6 h (B). After the designated time, an
aliquot of the bacterial culture was removed for A600 readings. Wells were
subsequently washed and stained for 10 min with 0.1% crystal violet. Excess
crystal violet was removed by washing and solubilized by addition of 30%
acetic acid. Biofilm formation was assessed by comparing the absorbance
ratio at 550 nm for crystal violet and 600 nm for bacteria. As seen in both
panels, T1SSmutants had significantly reduced ability to form biofilms; how-
ever, complemented strains had biofilm phenotypes similar to wild-typeM2.
For statistical analyses, one-way ANOVA with Tukey’s correction for multiple
comparisons was performed. *, p 0.01; **, p 0.001; ***, p 0.0001.
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logs of both bap and the RTX protein are also found in these
strains, highlighting their probable secretion by the T1SS.
The Acinetobacter T1SS is related to other ABC transport-
ers, like the resistance-nodulation-cell division (RND) efflux
pumps. Many RND pumps, such as AdeABC, AdeFGH, and
AdeIJK, have been extensively characterized in A. baumannii;
however, their roles in the pathobiology of Acinetobacter have
been linked directly with the efflux of small molecules, partic-
Figure 6. T1SShave anattenuatedvirulencephenotype in theG. mellonella infectionmodel.A–D, groups ofG. mellonella larvaewere injectedwith 10l
of either the parent strain, the tolCmutant (A), the hlyBmutant (B), the hlyDmutant (C), the full locusmutant (D), or the respective complemented strains at an
inoculum previously determined to be the equivalent of the LD50 for wild-typeM2. Larvae were checked for viability as determined bymelanin accumulation
and motility. Although not statistically significant as determined by Mantel-Cox comparison of survival curves, a clear attenuation trend was observed for all
mutants tested.
Figure 7. PathogenicAcinetobacter species encode for functional CDI systems.A, genetic arrangement and locus identifiers for theCDI locus in strainM2.Boxes
beloweachgene contain the relevantprotein family domain informationassociatedwith the respective aminoacid sequence forCdiB, CdiA, andCdiI, as determined
by BLASTp. B, growth inhibition assays for strain M2 cdimutants. Strain M2 is able to inhibit the growth of the cdimutant at a statistically significant level; however,
co-incubation between the cdimutant and the cdimutant complemented with the immunity protein alone, or between the wild type and the cdimutant comple-
mentedwiththe immunityprotein,didnotshowstatisticallysignificantdifferences.CDI-mediatedgrowth inhibitionwas independentof theT6SS,asshowninthe last
column.CandD,growthinhibitionassays inA. baumannii19606(C)andtheA.baumannii1225(D)mutantpanel.Both19606and1225encodefortwocdi loci,andboth
are able to inhibit the growth of mutants lacking the cognate immunity proteins. For statistical analyses, one-way ANOVA with Tukey’s correction for multiple
comparisonswasperformed forBandC,whereas anon-parametricKruskal-Wallis testwithDunn’s correction formultiple comparisonswasutilized forD. TheCDI loci
for 19606 can be foundwith the locus tags F911_RS14340 to F911_RS14350 for cdi_1 and F911_RS17415 to F911_RS17425 for cdi_2.
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ularly antibiotics, and not protein substrates (38–40). How-
ever, Yoon et al. (41) demonstrated that overexpression of the
RNDpumpsAdeABC andAdeIJK alters the composition of the
Acinetobacter outer membrane, as evidenced by the repression
of Csu pili, OmpA, and some metabolism-associated proteins,
demonstrating the importance of ABC transporters in outer
membrane homeostasis.
In a related fashion, we observed that mutations in the T1SS
altered the secretion profile compared with wild-typeM2. Spe-
cifically, our analysis identified that the T6SS is affected by
alterations to the T1SS, but only under nutrient limitation. Fur-
thermore, this abrogation is not due to membrane stress asso-
ciated with mutations in tolC, as mutants lacking the periplas-
mic adaptor protein HlyD or the ATPase HlyB also displayed
the samephenotype. Evenmore intriguing is that this reduction
in T6SS activity is specific for mutations in the T1SS, as muta-
tions that alter both T2SS and T4P functionality had not effect
on Hcp secretion. The fact that T6SS is only abrogated under
nutrient limitation in T1SS mutants suggests a regulatory
cross-talk that favors the functional activity of these two sys-
tems simultaneously, which has yet to be fully explained. These
results have parallels with cross-talk between secretion systems
in other bacteria. Specifically, others have shown that the T2SS
and T6SS of P. aeruginosa are co-regulated by quorum sensing
(42, 43), and transcription factors co-regulate the T3SS and
T6SS of Burkholderia cenocepacia (44). The regulatory mecha-
nism behind the Acinetobacter Hcp secretion repression in
T1SSmutants has yet to be determined but is not dependent on
the previously described plasmid regulation system found in
A. baumannii 17978 (15), given that M2 does not carry a ho-
mologous plasmid. Nevertheless, the levels of Hcp expression
in whole cells were equivalent across strains. Further, hcp is
predicted to be co-transcribed with the complete T6SS biogen-
esis machinery in a single operon. Based on these observations,
we hypothesize that the down-regulation of T6SS in the T1SS-
deficient strains takes place at the posttranscriptional level.
Several otherAcinetobacter isolates also expressHcp but do not
constitutively secrete Hcp (13). Additional work is needed to
understand T6SS regulation in Acinetobacter and its connec-
tions with other cellular processes.
Two of themost abundantly secreted proteins, the RTX pro-
tein and Bap, relied on the T1SS for export, as evidenced by
their relative absence in the T1SSmutant and the presence of a
type I C-terminal target domain (VC_A0849) in both proteins.
Little is known about the role of RTX domain-containing pro-
teins in the pathobiology ofAcinetobacter; however, De Grego-
rio et al. (33) have bioinformatically found that some Acineto-
bacter RTX domain-containing proteins also have bacterial
Ig-like domains found in Bap orthologs. These proteins, like
ABAYE0821 from A. baumannii AYE, also contain the same
peptidase M10 serralysin C-terminal domain found in the M2
RTX protein. Interestingly, all or some of these domains are
also commonly found in otherwell studied large repetitive RTX
proteins, like LapA from Pseudomonas fluorescens and Pseu-
domonas putida as well as SiiE from Salmonella enterica (34).
As shown in our proteomics data, the secondmost differentially
secreted protein between the wild type and the T1SS mutant
was the M215_02910 protein, which also contained multiple
bacterial Ig-like domains but not a type I C-terminal target
domain. It is tempting to speculate that these two proteins (RTX
andM215_02910) are actually a single protein constituting a new
member of the large repetitive RTXprotein family; however,mul-
tiple unsuccessful attempts were made to clone and resequence
the RTX gene. We hypothesize that, because of the presence of
extensive repetitive sequences in these genes, the original genome
sequence may be incorrect. Resequencing the genome of this
strain will be necessary to properly assemble these genes.
Although little is known aboutAcinetobacter large repetitive
RTX proteins, Bap orthologs have been studied in detail for
their role in Acinetobacter virulence and biofilm formation
(45–47). From a molecular standpoint, Bap has been shown to
be localized on the surface ofA. baumannii (45) and, as we have
shown, was readily identified in the culture supernatant. We
have also shown that Bap is likely secreted by the T1SS. These
results are congruent with those found for secretion of LapA,
whereby a T1SS-like system, designated LapEBC, is responsible
for its secretion (48). Nevertheless, molecular tagging experi-
ments are required to definitively linkAcinetobacter Bap secre-
tionwith the T1SS. From a phenotypic perspective, though, it is
likely that the attenuated biofilm formation was due to the
absence of Bap, given its previously characterized role in higher-
order biofilm structure and maintenance (33).
During the course of our characterization of the T1SS, we
identified a CdiAM2 polymorphic toxin. CDI systems, com-
posed of an outer membrane pore-forming protein, the poly-
morphic toxin, and an immunity protein, deliver toxic effectors
to neighboring bacteria to inhibit growth. CdiA toxins are usu-
ally large, repetitive proteins with multiple N-terminal hemag-
glutinin repeats and a polymorphic C-terminal toxin domain
(49). To date, CDI systems in Acinetobacter have been men-
tioned minimally in published reports, essentially just in bioin-
formatics comparisons of other previously well characterized
systems (50–52), and none have shown any functional demon-
stration of activity. Although we demonstrated that CDI sys-
tems are functional, we did not identify the toxin receptor or
the proposedmechanismof killing. However, the CdiAM2 toxin
contains domains associated with DNase/tRNase activity, indi-
cating that it may function as a cytoplasmic toxin degrading
nucleic acids. Aside from the assigned toxic activities, novel
signaling roles have been assigned to CDI systems, including
signaling to coordinate cooperation between bacteria that carry
the same cdi alleles (53). Given that CDI systems appear wide-
spread in Acinetobacter and that Acinetobacter is commonly
associated with polymicrobial infections, these systems may
also function as signaling molecules to coordinate killing activ-
ity in vivo.
Recently, a new contact-dependent killing system, designated
theCdz system,was discovered inCaulobacter crescentus andwas
also bioinformatically identified in A. baumannii (54). These sys-
tems share similarities with CDI systems but rely on a T1SS for
export of the surface-associated toxins. Further, the authors were
able to identify the putative toxins in A. baumannii. Unfortu-
nately, a BLASTp analysis revealed that there are no orthologs in
A. nosocomialis M2 for these putative A. baumannii Cdz toxins.
Nevertheless, it is likely that, in otherAcinetobacter strains encod-
ing for Cdz toxins, a T1SS is responsible for their secretion.
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Collectively, we have demonstrated the functionality of two
previously uncharacterized secretion systems in pathogenic
Acinetobacter: a T1SS that secretes two putative effectors and a
CDI system that mediates bacterial growth inhibition of sister
cells. Furthermore, using quantitative proteomics, wewere also
able to define the secretome of M2 in minimal medium. These
findings provide the foundation for future work aimed at deci-
phering the role of each system and other uncharacterized
secreted proteins in the pathobiology of Acinetobacter, ulti-
mately providing a framework of Acinetobacter virulence.
Experimental procedures
Strains, plasmids, and growth conditions
All strains used in this study are listed in supplemental Table
1. Bacteria were grown at 37 °C on L-agar, in LB broth, or inM9
salts supplemented with 0.2% casamino acids, 2 mM magne-
sium sulfate, and 100 M calcium chloride. When appropriate,
the following antibiotic concentrations were used: for E. coli,
100 g of ampicillin/ml and 20 g of kanamycin/ml. For Acin-
etobacter species, 200g of carbenicillin/ml, 7.5g of kanamy-
cin/ml, and 12.5 g of chloramphenicol/ml. Sucrose was used
at 10% for counterselection.
Mutant and complemented strain construction
Both marked and unmarked mutants were constructed
according to our protocols published previously (55). The com-
plete list of primers utilized for mutagenesis can be found in
supplemental Table 2. Briefly, for strain M2 derivatives, kana-
mycin-sacB-interrupted gene cassettes were generated using
In-Fusion HD EcoDry cloning kits (Takara Bio). Kanamycin-
sacB cassettes were introduced into strainM2 via natural trans-
formation, and transformants were selected on L-agar supple-
mented with 7.5g of kanamycin/ml. Unmarkedmutants were
generated by transiently introducing and expressing the flp
recombinase from pFLP2 via a triparental mating strategy
described previously (55). For A. baumannii 1225 and 19606,
unmarked in-framemutations were generated according to the
protocol of Tucker et al. (18).
Complemented mutants in the M2 background were gener-
ated by introducing a mini-Tn7 element via a four-parental
mating strategy described previously with the following modi-
fication (55): exconjugants were selected on L-agar supple-
mented with 200 g of carbenicillin/ml and 12.5 g of chlor-
amphenicol/ml. Complemented mutants in 19606 and 1225
were generated by cloning the respective cdi immunity gene
into pSH1. The plasmid pSH1was constructed by replacing the
multiple cloning site and promoter of pBAVMCSwith the araC
gene, PBAD promoter, and Shine-Dalgarno from pMLBAD
using the In-Fusion HD EcoDry cloning kit with the primers
listed in supplemental Table 2.
Secreted protein one dimensional SDS-PAGE analysis
Secreted proteins for one-dimensional SDS-PAGE analysis
were enriched from bacteria grown in LB medium overnight
(16 h) at 37 °C and 225 rpm. Briefly, overnight cultures were
normalized to A600  5.0, and 1.5-ml aliquots were removed
and pelleted. One milliliter of supernatant was removed, and
TCA was precipitated according to methods published pre-
viously (15). Precipitated protein was resuspended in 25
l and used for SDS-PAGE analysis followed by Coomassie
staining.
Secreted protein enrichment for quantitative proteomics
analysis
A. nosocomialis strain M2, the tolC-hlyD::kan mutant, and
its respective complement were grown overnight in 5 ml of M9
minimal medium supplemented with 0.2% casamino acids at
37 °C and 225 rpm. The following morning, each strain was
inoculated into 50 ml of minimal medium at A600 0.05. Bac-
teria were grown at 37 °C with 225 rpm for 3 h (approximately
mid-log). Cultures were removed from the incubator and cen-
trifuged at 15,000  g for 2 min, and supernatants were
removed. Supernatants were filter-sterilized with Steriflip
vacuum-driven filtration devices (Millipore) and concentrated
using an Amicon Ultra (Millipore) concentrator with a 10-kDa
molecular weight cutoff. Supernatants were concentrated to
150 l, flash-frozen in liquid nitrogen, and then lyophilized.
Lyophilized protein samples were then processed for mass
spectrometry analysis as described below. For each strain, four
individual 50-ml cultureswere prepared, providing four biolog-
ical replicates for each strain.
Digestion and dimethyl labeling of secretomes
Lyophilized secretomes from identical culture volumes were
resuspended in 6 M urea, 2 M thiourea, and 40 mM NH4HCO3
and reduced/alkylated prior to digestion with Lys-C (1/200
w/w) and then trypsin (1/50 w/w) overnight as described pre-
viously (56). Digested samples were acidified to a final concen-
tration of 0.5% formic acid and desalted usingC18 stage tips (57,
58) prior to reductive dimethylation labeling. C18 stage tips
were conditioned with buffer B (80% ACN, 0.1% formic acid)
and washed with 10 volumes of buffer A* (0.1% TFA, 2% aceto-
nitrile (ACN)). The sample was loaded, the columnwas washed
with 10 volumes of buffer A*, and bound peptides were eluted
with buffer B and then dried. Dimethylation was performed
according to the protocol of Parker et al. (59). Briefly, peptide
samples were resuspended in 30 l of 100 mM triethylammo-
niumbicarbonate by bath sonication and 30l of 200mM form-
aldehyde, followed by addition of 3 l of 1 M cyanoborohydride
to initiate amine labeling. For secretome samples derived from
wild-type strains, “light” combinations of formaldehyde and
cyanoborohydride were utilized (CH2O and NaBH3CN),
whereas the T1SS mutant and complemented strain were
labeled with “medium” (CD2O and NaBH3CN) and “heavy”
(13CD2O and NaBD3CN) reagents, respectively. The samples
were then incubated at room temperature in the dark for 1 h,
and two rounds of dimethyl labeling were undertaken to
ensure complete labeling. Labeling reactions were quenched
with 3 M NH4Cl and acidified with buffer A* prior to mixing.
Combined dimethylated samples were desalted with C18
stage tips prior to LC/MS analysis. A total of four biological
replicates of dimethylated secretomes were analyzed by
LC/MS.
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C18 stage tip-purified peptideswere resuspended in buffer A*
and loaded onto an in-house-packaged 35-cm, 75-m inner
diameter, 360-m outer diameter, 1.7-m, 130-Å CSH C18
(Waters, Manchester, UK) reverse-phase analytical column
with an integrated HF-etched nano-electrospray ionization
(nESI) tip. Samples were loaded directly onto the column using
an Acquity ultra performance liquid chromatography (UPLC)
M-class system (Waters) at 400 nl/min for 35minwith buffer A
(0.1% formic acid) and eluted at 300 nl/min using a gradient
altering the concentration of buffer B (99.9%ACN, 0.1% formic
acid) from0% to 32%B over 100min, then from32% to 40%B in
the next 10 min, then increased to 80% B over an 8-min period,
held at 100% B for 2 min, and then dropped to 0% B for another
20 min. reverse phase (RP)-separated peptides were infused
into a Q-Exactive (Thermo Scientific, San Jose, CA) mass spec-
trometer, and data were acquired using data-dependent acqui-
sition. One full precursor scan (resolution, 70,000; 350–2000
m/z; automatic gain control (AGC) target of 3 106), followed
by 10 data-dependent higher-energy collisional dissociation
(HCD) MS-MS events (resolution, 17.5 k automatic gain con-
trol (AGC) target of 1 105 with a maximum injection time of
200 ms, NCE 28 with 20% stepping), were allowed, with 35-s
dynamic exclusion enabled.
Data analysis
MaxQuant (v1.5.3.1) (60) was used for identification and
quantification of the experiments, with the resulting biological
replicates searched together to ensure a global false discovery
rate of less than 1% in accordance with the work of Schaab
et al. (61). Database searching was carried out against the A.
nosocomialisM2database (NCBIwhole genome sequence (WGS)
entry AWOW00000000, downloaded July 3, 2016) with the fol-
lowing search parameters: carbamidomethylation of cysteine as
a fixed modification, oxidation of methionine, acetylation of
protein N termini, trypsin/P cleavage with a maximum of two
missed cleavages. A multiplicity of three was used, with each
multiplicity denoting one of the dimethylation labeling com-
binations (light, medium, and heavy, respectively). The pre-
cursor mass tolerance was set to 50 ppm for the first search
and 10 ppm for the main search, with a maximum false
discovery rate of 1.0% set for protein identifications. To
enhance the identification of peptides between fractions and
replicates, theMatch between Runs option was enabled, with
a precursor match window set to 2 min and an alignment
window of 10 min. A minimum of two unique peptides was
required for protein quantification. The resulting protein
group output was processed within the Perseus (v1.4.0.6)
(62) analysis environment to remove reverse matches and
common protein contaminants prior to visualization of the
data with Matlab R2016a. The mass spectrometry proteom-
ics data have been deposited to the ProteomeXchange Con-
sortium via the PRIDE partner repository with the dataset
identifier PXD005881 (63).
Western blotting for Hcp secretion
HcpWestern blottingwas performed as described previously
(15). Briefly, cells were grown to mid-log and then normalized
to A600 0.5. One milliliter of culture was then centrifuged to
collect supernatants. Secreted proteins were precipitated using
TCA. Precipitated proteins were resuspended in 50 l of
Laemmli buffer, and 10 l was loaded onto polyacrylamide
gels. The anti-Hcp (13) and anti-RNA polymerase (Bioleg-
end, San Diego, CA) antibodies were both used at a concen-
tration of 1:1000. Secondary IRdye antibodies from Licor
were used at 1:10,000. All blots were blocked in TBS blocking
buffer (Licor).
Biofilm assay
96-well plate biofilm/crystal violet retention assays were
performed according to the following protocol. Bacteria
were grown overnight in 5 ml of LB medium at 37 °C and 225
rpm. The following day, each culture was normalized to
A600  1.0 and diluted 1:100 into 200 l of fresh LB broth.
Plates were statically incubated at 37 °C for 3 or 6 h. After the
designated time, an aliquot of the bacterial culture was
removed for A600 readings. Wells were subsequently washed
and stained for 10 min with 0.1% crystal violet. Excess crystal
violet was removed by washing and solubilized by addition of
30% acetic acid. Biofilm formation was assessed by compar-
ing the absorbance ratio at 550 nm for crystal violet and 600
nm for bacteria. Biofilm assays were performed three sepa-
rate times with three technical replicates per biological
replicate.
G. mellonella infectionmodel
The G. mellonella infection experiment was performed as
described in Harding et al. (10). Three groups of 10 larvae were
injected with the same LD50 established previously, and larva
viability was scored approximately every 5 h based on response
to physical stimuli and melanin accumulation.
CDI assay
Bacterial inhibition assays were performed utilizing a modi-
fied protocol from Weber et al. (15) for killing associated with
type VI secretion systems. Briefly, CDIAssays were set up using
overnight cultures normalized to A600  1.0. Strains grown
with antibiotics or 0.2% arabinose were washed prior to co-in-
cubation. Inhibitor and target strains weremixed at a 1:10 ratio,
and a 5-l suspensionwas spotted on a dry LB agar plate or a 1%
arabinose LB agar plate. After 4 h, the spot was cut out, resus-
pended in 1 ml of LB, and serially diluted on LB plates with the
appropriate antibiotics for colony-forming units (CFU) enu-
meration (either kanamycin, 20 g/ml for M2 cdimutants and
complemented strains, or rifampicin, 150 g/ml for A. bau-
mannii 19606 and 1225 cdi mutants and complemented
strains).
Statistical analyses
GraphPadPrism7 softwarewas used for statistical analyses of
biofilm formation, G. mellonella infection experiments, and
CDI assays. For normally distributed datasets, parametric one-
way ANOVA was performed with Tukey’s correction for mul-
tiple comparisons. For non-normally distributed datasets, non-
parametric Kruskal-Wallis test with Dunn’s correction for
multiple comparisons was used.
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